Warning letter
Thomas S. Tooma, M.D.: warning letter of Nov 2, 2015
FDA warning letter 480387 · Center for Drug Evaluation and Research
Key facts
| Reference number | 480387 |
|---|---|
| Company | Thomas S. Tooma, M.D. |
| Subject | Sponsor/Investigator |
| Issue date | Nov 2, 2015 |
| Posted date | Dec 1, 2015 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 312.20(a), 312.62(a), 312.2(a), 320.31, 312.52, 312.50, 312.7, 312.40, 56 |
| Inspection city | Newport Beach |
| Inspection ZIP | 92660 |
| Inspection start date | Jun 28, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: